Menu

Latest News

OCTOPUS has reached its goal of recruiting 375 people with progressive MS in the first stage of the trial. It will now seamlessly transition into the next stage.
We have pioneered several innovative designs to make randomised clinical trials more efficient and robust. This piece focuses on one such design, called Response Over Continuous Intervention (ROCI).
As part of our ‘25 at 25’ series, we look at how the PROMIS study has improved how prostate cancer is diagnosed, sparing thousands of men unnecessary biopsies.

This week, researchers from around the world will gather for The Union World Conference on Lung Health, held from 12-16 November in Bali, Indonesia.  Researchers from the MRC Clinical Trials Unit at UCL and our collaborators from other institutions will present our latest tuberculosis (TB) work, including new findings from the TB-CHAMP, TRUNCATE-TB and SURE trials, as well as ...

This latest episode of the Trial Talk podcast features four of the Unit’s early career researchers, each discussing the work they presented at ICTMC 2024.